In this issue
Risk factors for mortality, hospitalisation and imprisonment in substance misuse patientsSubscription
Pharmacists should be aware of the mortality rates and adverse outcomes, including hospitalisation and imprisonment, that are rife in illicit drug users and patients on opioid substitution therapy, in order to optimise patient safety and reduce adverse outcomes.
By using Oncotype DX test technology, researchers behind the TAILORx trial have proven that invasive and often harmful chemotherapy needn’t be the only option for women with breast cancer.
An overview of management options for type 1 diabetes, the types of insulin, insulin regimens and strengths available for its day-to-day management as well as how to adjust doses and the role of carbohydrate counting and blood glucose monitoring.
Women who continue taking olanzapine or quetiapine during pregnancy are more likely to develop gestational diabetes than those who discontinue atypical antipsychotic medication.
There is strong evidence that vaccination against human papillomavirus (HPV) between the ages of 15 and 26 years protects against cervical pre-cancer in young women, concluded the authors of a recent Cochrane Review (9 May 2018).
A new standard of inpatient opioid prescribing preferring oral and subcutaneous administration may be associated with significant reductions in intravenous opioid exposure, results from a US study show.
Patients given GLP-1 receptor agonists to treat obesity lost weight compared with those treated with placebo.
Research in practice has traditionally been the Cinderella of academia. Many pharmacists conduct service evaluations and audits, but often the findings are not published.